The highly respected UK publications Which
(formerly the Consumer's Association) and its sister publication Drug and Therapeutics Bulletin
(DTB) have long pointed out the failure of the MHRA (the UK drugs regulator) to act in a transparent manner or to provide reliable and timely information to doctors. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. Earlier this year, the Labour government pulled funding
for distribution of DTB to doctors without any consultation (Hansard
) attenuating this reliable information source. Why it did so can only be guessed.Which?
(October 2006 issue) continues to highlight the problems, touching also on the Sheffield
. At least someone is stating the obvious.Earlier
Labels: MHRA, Procter and Gamble